Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $4.77B
- P/E ratio
- —
- EPS
- —
- Volume
- 508,070
- 52-week high
- —
- 52-week low
- —
- Open
- $63.59
- Day high
- $65.00
- Day low
- $62.23
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $677.56M | $59.01M | $0.75 |
| 2024 | $423.24M | -$43.19M | -$0.60 |
| 2023 | $270.26M | $14.08M | $0.20 |
| 2022 | $220.18M | $183.36M | $2.60 |
| 2021 | $38.54M | -$157.92M | -$2.30 |
About Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
- CEO
- Sanj K. Patel
- Employees
- 366
- Country
- GB
- IPO date
- May 24, 2018
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's stock price today?
- KNSA is trading at $62.58 as of Jul 20, 2026.
- What is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's market cap?
- Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) has a market capitalization of $4.77B.
- Does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares pay a dividend?
- Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares in?
- Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares operates in the Healthcare sector.